EUS-Guided Biliary Drainage in Patients With Inoperable Malignant Distal Biliary Obstruction and Failed ERCP: a Prospective Feasibility Multicenter Trial

NCT01889953 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2015-05-25

No results posted yet for this study

Summary

This research is being done to study the safety and feasibility of recruiting patients eligible for EUS-guided biliary drainage (EGBD). Our goal is to prospectively study safety and effectiveness of this procedure.

Conditions

  • Malignant Distal Biliary Obstruction

Interventions

OTHER

EUS-guided biliary drainage

Based on the patient's condition, the will receive: * Rendezvous technique * Direct transluminal access transesophageal technique * Direct transluminal access transduodenal technique * or direct transluminal access using transgastric approach

Sponsors & Collaborators

  • Indiana University

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER
  • All India Institute of Medical Sciences

    collaborator OTHER
  • Winthrop University Hospital

    collaborator OTHER
  • University of Florida

    collaborator OTHER
  • The Mediterranean Institute for Transplantation and Advanced Specialized Therapies

    collaborator OTHER
  • Erasmus Medical Center

    collaborator OTHER
  • AdventHealth

    collaborator OTHER
  • Medical University of South Carolina

    collaborator OTHER
  • Institute of advanced endoscopy

    collaborator UNKNOWN
  • Aichi Cancer Center

    collaborator OTHER
  • Johns Hopkins University

    lead OTHER

Principal Investigators

  • Mouen A Khashab, MD · Johns Hopkins Hospital Department of Gastroenterology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • United States
  • India
  • Italy
  • Japan
  • Netherlands

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01889953 on ClinicalTrials.gov